Evidence for GABAergic inhibitory deficits in major depressive disorder
β Scribed by Paul E. Croarkin; Andrea J. Levinson; Zafiris J. Daskalakis
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 268 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0149-7634
No coin nor oath required. For personal study only.
β¦ Synopsis
Converging evidence suggests that deficits in gamma-aminobutyric acid (GABA) functioning are implicated in the pathophysiology of major depressive disorder (MDD). This is highlighted by research investigating cortical inhibition (CI), a process whereby GABAergic interneurons selectively attenuate pyramidal neurons. Transcranial magnetic stimulation (TMS) paradigms evaluate this marker of neuronal inhibitory activity in the cortex. This review will examine the neuroanatomic and neurophysiological evidence from neuroimaging, molecular, treatment, and TMS studies linking dysfunctional GABAergic neurotransmission to MDD.
π SIMILAR VOLUMES
Factors associated with people suffering from major depressive disorder (MDD) or anxiety disorders seeking or receiving treatment are not well known. In the Health 2000 Study, a representative sample (n=6005) of Finland's general adult (> or =30 years) population was interviewed with the M-CIDI for